12PMSI status plus immunoscore to select metastatic colorectal cancer patients for immunotherapies. (17th December 2018) - Galon, J; Mlecnik, B; Hermitte, F; Marliot, F; Bifulco, C; Lugli, A; Nagtegaal, I D; Hartmann, A; van den Eynde, M; Roehrl, M; Ohashi, P; Zavadova, E; et al.